Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
Workday
WDAY
US OptionsDetailed Quotes
MGNX250516P2000
- 1.27
- 0.000.00%
15min DelayClose Apr 25 16:00 ET
0.00High0.00Low
1.27Open1.27Pre Close0 Volume55 Open Interest2.00Strike Price0.00Turnover712.46%IV57.31%PremiumMay 16, 2025Expiry Date0.29Intrinsic Value100Multiplier21DDays to Expiry0.98Extrinsic Value100Contract SizeAmericanOptions Type-0.2231Delta0.1024Gamma1.35Leverage Ratio-0.0211Theta-0.0008Rho-0.30Eff Leverage0.0012Vega
Macrogenics Newsroom
MacroGenics (MGNX) Loses -48.74% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
New Analyst Forecast: $MGNX Given $2.0 Price Target
H.C. Wainwright Maintains Macrogenics(MGNX.US) With Hold Rating, Cuts Target Price to $2
Macrogenics Is Maintained at Neutral by HC Wainwright & Co.
Macrogenics Analyst Ratings
MacroGenics: Hold Rating Amidst Development Halts and Financial Challenges
Express News | MacroGenics, Inc. : H.c. Wainwright Cuts Target Price to $2 From $4
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Stifel Maintains Macrogenics(MGNX.US) With Hold Rating, Maintains Target Price $6
MacroGenics Axes ADC Drug Following Phase II Failure in Prostate Cancer
Q4 2024 MacroGenics Inc Earnings Call
Barclays Maintains Macrogenics(MGNX.US) With Buy Rating, Maintains Target Price $8
Barclays Sticks to Their Buy Rating for MacroGenics (MGNX)
TD Cowen Maintains Macrogenics(MGNX.US) With Hold Rating
JMP Securities Maintains Macrogenics(MGNX.US) With Hold Rating
MacroGenics Hold Rating: Uncertainty in Pipeline and Fair Valuation Amidst Anticipated 2025 Updates
MacroGenics (MGNX) Gets a Hold From TD Cowen
MacroGenics (MGNX) Q4 2024 Earnings Call Transcript
Earnings Call Summary | Macrogenics(MGNX.US) Q4 2024 Earnings Conference
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
